773134-91-1Relevant articles and documents
COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS
-
Page/Page column 157-158, (2019/04/26)
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.
Bicyclic pyrazole compounds as antibacterial agents
-
Page/Page column 26-27, (2010/11/24)
Antibacterial compounds, compositions containing them, and methods of use for the inhibition of bacterial activity and the treatment, prevention or inhibition of bacterial infection.